At the core of our technology lies a sophisticated application of
the Gate Control Theory by Melzack and Wall, which revolutionized
our understanding of pain. This theory elucidates that pain is not
merely a direct result of activation of pain nerve fibers but is
also significantly modulated by interplay between different types of
nerves. The A-delta fibers, which are fast-conducting and respond to
acute, well-defined pain, and the slower, chronic pain-transmitting
C fibers, converge on the same nerve gate in the spinal cord.
Our VR technology, informed by this theory, strategically engages
the brain's attention and alters pain perception by creating an
immersive environment that can preferentially stimulate these neural
pathways. When coupled with Cognitive Behavioral Therapy, which
empowers patients with pain management strategies, our VR experience
not only 'closes' the neurological gate to pain signals but also
reinforces the patient's ability to control and diminish the
psychological impact of pain. This integrative approach paves the
way for a comprehensive pain management system that addresses both
the physiological and psychological dimensions of pain.
Highly Immersive, Gamified Experience
We customize VR pain relief treatments for patients based on their
specific pain conditions. In immersive, gamified environments,
patients undergo a series of functional training exercises aimed at
pain relief, including breathing exercises, progressive relaxation
training, gate control training, and attention diversion training.
Within these realistic settings, patients learn to control their
breathing, relax muscles, increase pain tolerance, and deeply engage
in activities that divert attention from pain, all in an easy,
relaxing, and stress-free environment.
Published Research Papers
Quantum Clinics & Tianjin Medical University General Hospital’s VR Study Published in International Journal of Surgery: A New Frontier in Postoperative Pain Management (2025-01-29)
A groundbreaking randomized controlled trial (RCT) co-led by Quantum Clinics and Tianjin Medical University General Hospital demonstrated the efficacy of virtual reality (VR) in alleviating acute pain after thoracoscopic surgery. Published in International Journal of Surgery (IF 15.3, JCR Q1) in 2025, this study pioneers a non-pharmacological approach to postoperative care with significant clinical implications.
Key Outcomes：In this triple-arm RCT involving 61 patients:
Pain Reduction: QTC-VR group showed statistically lower pain scores vs. placebo on postoperative days 1-3;
Improvement in Quality of Life: Marked improvements in emotion regulation, sleep quality, and mobility;
High Acceptance: 90.5% of participants rated QTC-VR as "satisfactory," with 81% willing to reuse the technology.
Our findings have validated QTC VR therapy as a potential scalable adjunct to traditional analgesia. This digital intervention minimizes opioid reliance while enhancing recovery quality.
Citation：Cao W et al. Int J Surg. 2025. doi:10.1097/JS9.000000000002264
